Kenneth D. Poss and David M. Tobin Named Fellows of the American Association for the Advancement of Science
Two of the seven Duke University faculty members named Fellows of the American Association for the Advancement of Science (AAAS) today are faculty in the School of Medicine. The prestigious appointment is obtained through peer nomination and is based on scientifically or socially distinguished efforts to advance science or its applications.
School of Medicine Teams Receive Duke Incubation Fund Awards for Early-Stage Innovations
The winners of the Fall 2019 Duke Incubation Fund awards have been announced, representing promising innovation happening across the University. Seven projects will receive funds totaling $129,000.
School of Medicine Faculty Recognized on ‘Highly Cited’ List
Fifty-four members of Duke’s faculty are included in the 2019 Highly Cited Researchers list compiled by ISI-Web of Science and Clarivate Analytics. More than half of them (37) are from the School of Medicine.
A high citation rate is an indication that a researcher’s work is influential in their field. Globally, Duke is in a four-way tie for eighth place with MIT, Memorial Sloan Kettering Cancer Center, and the University of California San Diego. In 2018, Duke was tied for 12th worldwide.
Bridges to Excellence: Improving Diverse Students’ Transitions from College to Medical School
Duke University School of Medicine, the East Carolina University Brody School of Medicine, and the University of South Carolina Greenville School of Medicine are to open a new avenue for talented college students from underrepresented populations to enroll and succeed at leading medical schools in the Carolinas.
Bridges to Excellence (BTE) creates a novel partnership among these schools to recruit and support talented underrepresented students who aspire to provide health care in underserved communities.
Duke Immunology Student, Lindsay Dahora, reflects on reasons to take the CliftonStrengths assessment
Fourth-year Ph.D. candidate Lindsay Dahora describes what she gained from taking the CliftonStrenghts assessment. Read her story at:https://gradschool.duke.edu/professional-development/blog/cliftonstreng…
If you are interested in taking the assessment and learning more about your personal strengths, e-mail heather.nickel@duke.edu
School of Medicine Partners with CSL Behring to Accelerate Faculty Research into new Technologies
In line with the Duke University School of Medicine research strategic plan, which identifies industry partnerships as a critical enabler to support faculty research, the School has formed a promising new partnership with global biotechnology company CSL Behring with the goal of accelerating research and identifying and commercializing new technologies.
The partnership came about as a result of work led by Adrian Hernandez, MD, vice dean of clinical research, who has been actively networking with industry leaders for the past year.
Translating Duke Health Initiative Celebrates Two Years of Success
So far, 24 grants have been awarded totaling more than 2.8 million in seed funding. Eight School of Medicine departments have participated to recruit 17 strategic hires, called TDH Scholars, with additional recruitments ongoing. Twelve million dollars has been earmarked to support research infrastructure to accelerate discovery, including such things as a biobanking resource, and 24 educational symposia were hosted to bring together basic scientists, clinicians, and population health thought leaders.
Duke Offers Training, Tools and Resources as Part of Commitment to Scientific Integrity
Duke University has elevated its commitment to scientific integrity with new mandatory research training for faculty and staff, new educational opportunities, and the announcement of new leadership roles.
Executive Coaching Program
As the new academic year begins, the Office for Faculty would like to make you aware of two exciting updates to the School of Medicine Executive Coaching Program.
Duke Researchers Find Simpler, More Effective Cancer Vaccine Approach
Monocytes trigger a better immune response in mice than current dendritic cell vaccines
Using a precursor to dendritic cells appears to be an efficient and effective way to stimulate the immune system to fight cancer tumors, according to a study in animal and cell models by researchers at the Duke Cancer Institute.